homeschoolmom
New Member
- Joined
- May 3, 2014
- Messages
- 3
Has anyone experienced arthritic like pain in joints and all over body aches from allergy meds? I am. I am wondering if the med is causing some stress response?
Follow along with the video below to see how to install our site as a web app on your home screen.
Note: This feature may not be available in some browsers.
Click Here if you want to upgrade your account
If you were able to post but cannot do so now, send an email to admin at raypeatforum dot com and include your username and we will fix that right up for you.
Mittir said:My experience is that all the antihistamines, including cyproheptadine and Benadryl,
cause some kind of problem which out weighs the benefit. Low starch and extra calcium have been very helpful in managing allergy. I do feel muscle weekness from antihistamine, that probably happens due to dehydration. I think for occassional use very small dose of
Benadryl or cypro is fine.
Edit: I have just checked inactive ingredients in Zyrtec.
Inactive ingredients
colloidal silicon dioxide, hydroxypropyl cellulose, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, talc, yellow iron oxide
I believe colloidal silicon dioxide is a nano particle and RP has mentioned
these can cause serious health issues once it gets inside the body.
classicallady said:I haven't done an exhaustive search, but I found this to be interesting; see under, "Antihistamines".
http://www.naturaleyecare.com/FAQ/quest ... m-eyes.asp
Peata said:classicallady said:I haven't done an exhaustive search, but I found this to be interesting; see under, "Antihistamines".
http://www.naturaleyecare.com/FAQ/quest ... m-eyes.asp
Let us know how the taurine works for you. I've taken axtazanthin before and didn't notice any difference in floaters. But I just got a bottle of taurine. I got it for other purposes, but it will be nice if it helped clear floaters too.
classicallady said:Peata said:classicallady said:I haven't done an exhaustive search, but I found this to be interesting; see under, "Antihistamines".
http://www.naturaleyecare.com/FAQ/quest ... m-eyes.asp
Let us know how the taurine works for you. I've taken axtazanthin before and didn't notice any difference in floaters. But I just got a bottle of taurine. I got it for other purposes, but it will be nice if it helped clear floaters too.
I'll let you know. I haven't taken it consistently or long enough yet. Not sure how much I should be taking per day, but I've been doing the recommended dose of 500mg-- how about you? What other benefits of taurine? Do you have a lot of floaters? My new ones came on suddenly, it was somewhat scary. I hope they fade!
IIRC, Zyrtec is a 2nd generation antihistamine which can be pretty toxic to the liver for some people. It is recommended to use 1st generation like Benadryl or Cyproheptadine. I told Peat I was using Zyrtec and he sent me studies on how toxic it is to the liver. I immediately stopped and switched to cyproheptadine.
IIRC, Zyrtec is a 2nd generation antihistamine which can be pretty toxic to the liver for some people. It is recommended to use 1st generation like Benadryl or Cyproheptadine. I told Peat I was using Zyrtec and he sent me studies on how toxic it is to the liver. I immediately stopped and switched to cyproheptadine.
Ann Hepatol. 2011 Apr-Jun;10(2):237-8.@charlie Think you could dig up the email with those studies? My mother takes zyrtec every day for her allergies
Ann Hepatol. 2011 Apr-Jun;10(2):237-8.
Levocetirizine induced hepatotoxicity in a patient with chronic urticaria.
Ekiz F, Yüksel I, Ekiz O, Coban S, Basar O, Yüksel O.
2. Med Clin (Barc). 2011 Sep 10;137(6):283-4.
[Cetirizine hepatotoxicity].
[Article in Spanish]
Prieto de Paula JM, Franco Hidalgo S, Nalotto L, Ginés Santiago A.
3. N Z Med J. 2010 Feb 19;123(1309):106-7.
Severe hepatitis in a primary sclerosing cholangitis patient receiving recent
cetirizine therapy.
Jurawan R, Smith A.
4. Gastroenterol Hepatol. 2010 Jan;33(1):68-9. Epub 2009 Sep 3.
[Benign recurrent intrahepatic cholestasis simulating cetirizine-induced toxic
hepatitis].
[Article in Spanish]
Díaz-Sánchez A, Marín-Jiménez I, Aldeguer M.
5. Ann Pharmacother. 2004 Nov;38(11):1844-7. Epub 2004 Sep 21.
Recurrent acute hepatitis associated with use of cetirizine.
Pompili M, Basso M, Grieco A, Vecchio FM, Gasbarrini G, Rapaccini GL.
Department of Internal Medicine, Università Cattolica del Sacro Cuore, Rome,
Italy. [email protected]
OBJECTIVE: To describe a case of recurrent acute hepatitis related to the use of
cetirizine, a selective histamine(1)-receptor antagonist approved for the
treatment of common allergic diseases.
CASE SUMMARY: A 26-year-old man was hospitalized with a week-long history of
weakness, nausea, anorexia, and hyperchromic urine, which had developed after 6
days of therapy with oral cetirizine 10 mg/day for allergic rhinitis. Admission
laboratory testing revealed evidence of acute hepatitis and seropositivity for
liver-kidney microsome antibodies. Liver biopsy findings of diffuse portal tract
and lobular inflammation with a prominent eosinophilic infiltrate were consistent
with drug-related hepatitis. The patient was discharged after one week of
treatment with tocopherol and glutathione. Three months after discharge,
transaminase levels were normal. At 6 months, seropositivity for liver-kidney
microsome antibodies was still present, but considerably less intense. The
patient had suffered 2 previous episodes of "acute hepatitis of unknown origin,"
and both had occurred after cetirizine use.
DISCUSSION: Use of the Naranjo probability scale indicated cetirizine as the
probable cause of acute hepatitis, and the positivity for liver-kidney microsome
antibodies is suggestive of an autoimmune mechanism for liver damage. As of
September 13, 2004, ours is the fourth reported case of acute hepatitis
associated with cetirizine and the second in which liver-kidney microsome
antibodies have been documented.
CONCLUSIONS: Although cetirizine is considered to have low potential for severe
hepatic toxicity, the possibility that it can provoke autoimmune-mediated
hepatotoxicity should be considered.
6. Clin Allergy Immunol. 2002;17:389-419.
Potential cardiac toxicity of H1-antihistamines.
Yap YG, Camm AJ.
St. George's Hospital Medical School, London, England.
Nonsedating H1-antihistamines are widely prescribed for the treatment of allergic
disorders because of their lack of sedative and anticholinergic effects; however,
certain nonsedating antihistamines such as terfenadine and astemizole are now
known to cause QT prolongation and TdP, particularly in overdosage or with
concomitant ingestion of imidazole antifungals or macrolide antibiotics.
Mechanistic studies showed that the cardiotoxic effects of some nonsedating
antihistamines are due to the inhibition of repolarization potassium channels,
particularly IKr, which leads to prolongation of the action potential and QT
interval, and the development of early after-depolarization, which triggers TdP.
Patients at risk of developing TdP, such as those with congenital long QT
syndrome, cardiac disease, liver disease, electrolyte disturbance, or those
taking drugs that can prolong QT interval, should avoid nonsedating
antihistamines that are also capable of prolonging the QT interval. Many
questions still need to be answered, such as the role of other potassium channels
(IKs, ITo, and Iped) and the relative expression of various potassium channels in
different individuals, which may be important in the pathogenesis of TdP with
nonsedating antihistamines. There is also a lack of information on the cardiac
actions of newer nonsedating antihistamines. The evidence so far indicates that
the potential to cause ventricular arrhythmias is not a class effect and that
loratadine, cetirizine, and fexofenadine are not associated with QT prolongation,
TdP, or other ventricular arrhythmias. It is hoped that with a better
understanding of the arrhythmogenic mechanism of nonsedating antihistamines, we
will be able to identify patients at risk and prevent any cardiac toxicity
associated with H1-antihistamines, and ultimately, death.
7. J Clin Gastroenterol. 2002 Apr;34(4):493-5.
Acute hepatitis associated with cetirizine intake.
Sánchez-Lombraña JL, Alvarez RP, Sáez LR, Oliva NP, Martínez RM.
8. Ann Intern Med. 2001 Jul 17;135(2):142-3.
Severe hepatitis in a patient taking cetirizine.
Watanabe M, Kohge N, Kaji T.
9. J Clin Gastroenterol. 2000 Oct;31(3):250-3.
Cetirizine-induce cholestasis.
Fong DG, Angulo P, Burgart LJ, Lindor KD.
Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota
55905, USA.
Cetirizine, a human metabolite of hydroxyzine, is a selective H1-receptor
antagonist currently approved for the treatment of seasonal allergic rhinitis,
perennial allergic rhinitis, and chronic urticaria. In U.S. clinical trials,
transient reversible hepatic transaminase elevations were observed in <2% of
patients during cetirizine therapy. We report a case of cetirizine-induced
cholestasis in a 28-year-old man with no previous hepatobiliary disease after a
2-year period of taking cetirizine on a daily basis. The treatment of this
patient included the use of ursodeoxycholic acid, as well as hydroxyzine, for
symptomatic relief of pruritus. In light of the patient's clinical and
biochemical improvement while using hydroxyzine, it appears that the hepatic
metabolism of hydroxyzine to metabolites, including cetirizine, is not involved
in the pathogenesis of this particular case of drug-induced hepatotoxicity.
Cetirizine should be considered as a potential cause of drug-induced cholestasis.